Trimetazidine in chronic heart failure patients aged above 75 years
Aim. То assess 12-week trimetazidine therapy (Preductal® MB, 70 mg/d) effects on clinical status, quality of life (QoL), endothelial function, and myocardial contractility in chronic heart failure (СHF) and coronary heart disease (CHD) patients aged above 75 years. Material and methods. In total, 11...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
1970-01-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1534 |